The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
The Role of Immune System in Schizophrenia
Open accessAbstract
Although an immune dysfunction and the involvement of infectious agents in the pathophysiology of schizophrenia are discussed since decades, the field never came into the mainstream of research. In schizophrenia a blunted type-1 immune response seems to be associated with a dysbalance in the activation of the enzyme indoleamine 2,3-dioxygenase (IDO) and in the tryptophan - kynurenine metabolism resulting in increased production of kynurenic acid in schizophrenia. This is associated with an imbalance in the glutamatergic neurotransmission, leading to an NMDA antagonism in schizophrenia. The immunological effects of antipsychotics rebalance partly the immune imbalance and the overweight of the production of the kynurenic acid. This immunological imbalance results in an inflammatory state combined with increased prostaglandin E(2) (PGE(2)) production and increased cyclo-oxygenase-2 (COX-2) expression. COX-2 inhibitors have been tested in clinical trials, pointing to favourable effects in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Common variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677
Common variants on chromosome 6p22.1 are associated with schizophrenia
Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe’er, I., Dudbridge, F., Holmans, P. A., Whittemore, A. S., Mowry, B. J., et al. (2009) · Nature · doi:10.1038/nature08192 · Cited by 1,170
Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., Babulas, V. P., & Susser, E. S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.774 · Cited by 1,053
Prenatal developmental disturbances in the limbic allocortex in schizophrenics
Jakob, H., & Beckmann, H. (1986) · Journal of Neural Transmission · doi:10.1007/bf01249090 · Cited by 875
Hilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Steen, R. G., Mull, C., Mcclure, R., Hamer, R. M., & Lieberman, J. A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.6.510 · Cited by 832
Tolerance, DCs and tryptophan: much ado about IDO
Grohmann, U. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00072-3 · Cited by 766
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
Müller, N., & Schwarz, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002006 · Cited by 670
Self-citationvan Berckel, B. N., Bossong, M. G., Boellaard, R., Kloet, R., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A. D., Cahn, W., Lammertsma, A. A., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.025 · Cited by 582
Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
Schwarcz, R., & Pellicciari, R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556
Prenatal Infection as a Risk Factor for Schizophrenia
Brown, A. S. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj052 · Cited by 539
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Kynurenine pathway in major depression: Evidence of impaired neuroprotection
Myint, A.-M., Kim, Y. K., Verkerk, R., Scharpé, S., Steinbusch, H., & Leonard, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.013 · Cited by 527
Aloisi, F., Ria, F., & Adorini, L. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01512-1 · Cited by 392
Müller, N., Riedel, M., Scheppach, C., Brandstätter, B., Sokullu, S., Krampe, K., Ulmschneider, M., Engel, R. R., Möller, H.-J., & Schwarz, M. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1029 · Cited by 388
Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.
Takikawa, O., Yoshida, R., Kido, R., & Hayaishi, O. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35696-x · Cited by 377
Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring
Zuckerman, L., & Weiner, I. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.08.008 · Cited by 352
Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329
Evidence for activation of microglia in patients with psychiatric illnesses
Bayer, T. A., Buslei, R., Havas, L., & Falkai, P. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00545-5 · Cited by 323
The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6
Lin, A., Kenis, G., Bignotti, S., Tura, G.-J.-B., De Jong, R., Bosmans, E., Pioli, R., Altamura, C., Scharpé, S., & Maes, M. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00034-6 · Cited by 321
AKHONDZADEH, S., TABATABAEE, M., AMINI, H., AHMADIABHARI, S., ABBASI, S., & BEHNAM, B. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.016 · Cited by 289
Theories of schizophrenia: a genetic-inflammatory-vascular synthesis
Hanson, D. R., & Gottesman, I. I. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-7 · Cited by 276
IL-12 production by central nervous system microglia is inhibited by astrocytes
Aloisi, F., Penna, G., Cerase, J., Menéndez Iglesias, B., & Adorini, L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.4.1604 · Cited by 252
Dalman, C., Allebeck, P., Gunnell, D., Harrison, G., Kristensson, K., Lewis, G., Lofving, S., Rasmussen, F., Wicks, S., & Karlsson, H. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050740 · Cited by 247
Winter, C., Djodari-Irani, A., Sohr, R., Morgenstern, R., Feldon, J., Juckel, G., & Meyer, U. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009206 · Cited by 242
Miller, C. L., Llenos, I. C., Dulay, J. R., Barillo, M. M., Yolken, R. H., & Weis, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.015 · Cited by 233
Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness
Ganguli, R., Yang, Z., Shurin, G., Chengappa, K. N. R., Brar, J. S., Gubbi, A. V., & Rabin, B. S. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90042-6 · Cited by 222
T-helper-1 and T-helper-2 Responses in Psychiatric Disorders
Schwarz, M. J., Chiang, S., Müller, N., & Ackenheil, M. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0647 · Cited by 221
Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease
Mittleman, B. B., Castellanos, F. X., Jacobsen, L. K., Rapoport, J. L., Swedo, S. E., & Shearer, G. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.6.2994 · Cited by 218
Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., Babulas, V. P., & Susser, E. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000151642.60544.d2 · Cited by 216
Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types
HEYES, M. P., CHEN, C. Y., MAJOR, E. O., & SAITO, K. (1997) · Biochemical Journal · doi:10.1042/bj3260351 · Cited by 214
Th1, Th2 and Th3 cytokine alteration in schizophrenia
Kim, Y.-K., Myint, A.-M., Lee, B.-H., Han, C.-S., Lee, H.-J., Kim, D.-J., & Leonard, B. E. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.047 · Cited by 187
Potential Roles of Histones in Host Defense as Antimicrobial Agents
Kawasaki, H., & Iwamuro, S. (2008) · Infectious Disorders - Drug Targets · doi:10.2174/1871526510808030195 · Cited by 176
Casolini, P., Catalani, A., Zuena, A. R., & Angelucci, L. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10192 · Cited by 174
Wilke, I., Arolt, V., Rothermundt, M., Weitzsch, C., Hornberg, M., & Kirchner, H. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190280 · Cited by 171
Versijpt, J. J., Dumont, F., van Laere, K. J., Decoo, D., Santens, P., Audenaert, K., Achten, E., Slegers, G., Dierckx, R., & Korf, J. (2003) · European Neurology · doi:10.1159/000070857 · Cited by 166
Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF
Rothermundt, M., Falkai, P., Ponath, G. D., Abel, S., Bürkle, H., Diedrich, M., Hetzel, G., Peters, M., Siegmund, A., Pedersen, A., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001548 · Cited by 157
M�ller, N., Ulmschneider, M., Scheppach, C., Schwarz, M., Ackenheil, M., M�ller, H.-J., Gruber, R., & Riedel, M. J. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0478-1 · Cited by 156
Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia
Chakos, M., Schobel, S., Gu, H., Gerig, G., Bradford, D. W., Charles, C. H., & Lieberman, J. A. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.1.26 · Cited by 149
Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype
Garver, D. L., Tamas, R. L., & Holcomb, J. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300217 · Cited by 148
Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia
Rapaport, M. H., Delrahim, K. K., Bresee, C. J., Maddux, R. E., Ahmadpour, O. A., & Dolnak, D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.024 · Cited by 137
Cellular immunity in schizophrenic patients before and during neuroleptic treatment
Müller, N., Ackenheil, M., Hofschuster, E., Mempel, W., & Eckstein, R. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90072-w · Cited by 130
Müller, N., Empl, M., Riedel, M. J., Schwarz, M., & Ackenheil, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02922260 · Cited by 127
Gogtay, N., Lu, A., Leow, A. D., Klunder, A. D., Lee, A. D., Chavez, A., Greenstein, D., Giedd, J. N., Toga, A. W., Rapoport, J. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806485105 · Cited by 125
Kynurenate production by cultured human astrocytes
Kiss, C., Ceresoli‐Borroni, G., Guidetti, P., Zielke, C. L., Zielke, H. R., & Schwarcz, R. M. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0770-z · Cited by 121
The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view
Müller, N., & Schwarz, M. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_33 · Cited by 117
Childhood central nervous system infections and risk for schizophrenia
Koponen, H., Rantakallio, P. T., Veijola, J. M., Jones, P. B., Jokelainen, J. J., & Isohanni, M. K. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0485-2 · Cited by 112
Meisenzahl, E. M., Rujescu, D., Kirner, A., Giegling, I., Kathmann, N., Leinsinger, G. L., Maag, K. P., Hegerl, U., Hahn, K. M., & Möller, H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1316 · Cited by 111
Cytokines production in chronic schizophrenia patients with or without paranoid behaviour
Cazzullo, C. L., Scarone, S., GRASSI, B., Vismara, C. S., Trabattoni, D., Clerici, M., & Clerici, M. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00059-1 · Cited by 108
Cao, C., Matsumura, K., Ozaki, M., & Watanabe, Y. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00716.1999 · Cited by 105
Cellular and Humoral Immune System in Schizophrenia: A Conceptual Re-Evaluation
Müller, N., Riedel, M. J., Ackenheil, M., & Schwarz, M. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150588 · Cited by 99
Schwarz, M., Riedel, M. J., Ackenheil, M., & Müller, N. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00206-1 · Cited by 96
Dong, E., Grayson, D. R., Guidotti, A., Ruzicka, W. B., Veldić, M., & Costa, E. (2007) · Epigenetics · doi:10.4161/epi.2.1.4063 · Cited by 94
Grey matter changes can improve the prediction of schizophrenia in subjects at high risk
Job, D. E., Whalley, H. C., McIntosh, A. M., Owens, D. G. C., Johnstone, E. C., & Lawrie, S. M. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-29 · Cited by 93
Sperner‐Unterweger, B., Whitworth, A. B., Kemmler, G., Hilbe, W., Thaler, J., Weiß, G., & Fleischhacker, W. W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00175-3 · Cited by 86
Körschenhausen, D. A., Hampel, H. J., Ackenheil, M., Penning, R., & Müller, N. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00073-9 · Cited by 86
Chiarugi, A., Carpenedo, R., & Moroni, F. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020692.x · Cited by 84
Schwieler, L., Erhardt, S., Erhardt, C., & Engberg, G. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0231-y · Cited by 81
Associations between Chlamydophila infections, schizophrenia and risk of HLA-A10
Fellerhoff, B., Laumbacher, B., Mueller, N., Gu, S., & Wank, R. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001925 · Cited by 78
Serum interleukin-18 levels are elevated in schizophrenia
Tanaka, K. F., Shintani, F., 藤井, 康., Yagi, G., & Asai, M. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00196-7 · Cited by 78
The Risk for Schizophrenia From Childhood and Adult Infections
Brown, A. S. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07101637 · Cited by 78
Maternal Recall of Pregnancy History: Accuracy and Bias in Schizophrenia Research
Buka, S. L., Goldstein, J. M., Seidman, L. J., & Tsuang, M. T. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033457 · Cited by 77
Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function
Hu, F., Wang, X., Pace, T. W. W., Wu, H., & Miller, A. H. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001644 · Cited by 76
ller, N. M. ⁄., Riedel, M. J., Hadjamu, M., Schwarz, M., Ackenheil, M., & Gruber, R. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.634 · Cited by 72
Decreased T cellular immune response in schizophrenic patients
Riedel, M., Spellmann, I., Schwarz, M., Strassnig, M., SIKORSKI, C., MOLLER, H., & Müller, N. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.11.007 · Cited by 71
The Effects of Memantine on Prepulse Inhibition
Swerdlow, N. R., van Bergeijk, D. P., Bergsma, F., Weber, E., & Talledo, J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.7 · Cited by 69
Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients
Müller, N., Dobmeier, P., Empl, M., Riedel, M. J., Schwarz, M., & Ackenheil, M. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)84789-x · Cited by 62
Childhood meningitis, brain maturation and the risk of psychosis*
Gattaz, W. F., Abrah�o, A. L., & Foccacia, R. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0431-3 · Cited by 54
Bresee, C. J., & Rapaport, M. H. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000315 · Cited by 51
Fundamentals of Psychoneuroimmunology
Song, C., & Leonard, B. E. (2000) · Cited by 43
Relationship between immune and behavioral measures in schizophrenia
van Kammen, D. P., McAllister, C. G., & Kelley, M. E. (1997) · Key topics in brain research · doi:10.1007/978-3-7091-6870-7_7 · Cited by 39
Hyposensitivity to foreign protein in schizophrenic patients
Molholm, H. B. (1942) · Psychiatric Quarterly · doi:10.1007/bf01573918 · Cited by 38
Pollmächer, T., Schuld, A., Kraus, T., Haack, M., & Hinze‐Selch, D. (2001) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2001-16533 · Cited by 31
Measurement of neopterin, kynurenine and tryptophan in sera of schizophrenic patients
Sperner‐Unterweger, B., Miller, C., Holzner, B., Widner, B., Fleischhacker, W. W., & Fuchs, D. (1999) · Key topics in brain research · doi:10.1007/978-3-7091-6404-4_12 · Cited by 29
Die Wirkung der Neuroleptica-Behandlung auf die Antikörperbildung
Özek, M., Töreci, K., Akkök, I., & Güvener, Z. (1971) · Psychopharmacology · doi:10.1007/bf02419063 · Cited by 26
Müller, N., Riedel, M. J., Schwarz, M., Gruber, R., & Ackenheil, M. (1997) · Key topics in brain research · doi:10.1007/978-3-7091-6870-7_8 · Cited by 21
Cited by
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Müller, N. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby024 · Cited by 648
Self-citationFillman, S. G., Cloonan, N., Catts, V. S., Miller, L. C., Wong, J., McCrossin, T., Cairns, M., & Weickert, C. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.110 · Cited by 609
Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, P. B. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030516 · Cited by 582
The immune system and developmental programming of brain and behavior
Bilbo, S. D., & Schwarz, J. M. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.08.006 · Cited by 580
Metadata
- Authors
- Muller, N., & J. Schwarz, M.
- Venue
- Current Immunology Reviews
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-08-01
- Volume
- 6
- Issue
- 3
- Pages
- 213-220
- ISSN
- 1573-3955 (ISSN-L)
- OpenAlex
- W1555366957
- Cited by
- 291
- References
- 80
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.